The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

William Parks is a Game Rant editor who specializes in puzzle games, indie releases, Nintendo titles, and completion-focused guide coverage. Since joining Game Rant in 2019, he has written and edited ...

Last month, Anthropic announced a billing change that would have substantially increased costs for heavy users of its automation-focused Claude Agent SDK, including many third-party apps. On Monday, ...

A Silicon Valley software maker and an ecommerce company reveal to WIRED how they are navigating the emerging challenge of “tokenomics.” At the software company 8x8, employees are using Anthropic’s ...

The upgraded KCS experience brings trading efficiency, rewards, payment benefits and ecosystem privileges into one unified user journey. As digital asset ecosystems mature, the role of exchange-native ...

OpenAI is considering drastically lowering the prices it charges users as it seeks to win customers from its rival Anthropic. The company is weighing significant cuts to what it charges for tokens, ...

NEW YORK, June 17 (Reuters) - U.S. equity markets face a potential shakeup as the Securities and Exchange Commission readies a new policy that would allow crypto companies to offer blockchain-based ...

A year ago, the smart move inside a big company was to use as much AI as humanly possible. Some firms even ranked employees on leaderboards by how many tokens they burned, a status game that earned ...

Anthropic is releasing Claude Fable 5 for general users. Fable 5 uses Mythos-class power with safety controls. Pricing is about twice that of Claude Opus 4.8. Anthropic has announced a defanged ...

Fortnite Chapter 7 is here, sweeping players away to the United States' West Coast. This massive update introduces a complete map overhaul featuring brand-new Points of Interest and landmarks, fresh ...

Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Kelly ...

GLP-1 stocks are an interesting option for investors, as GLP-1 drugs are transforming healthcare in the modern age. Initially developed for type 2 diabetes, these drugs have demonstrated significant ...